The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 48%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (7 analysts) rates it buy, with a mean price target of $136.
Hamilton Lane Incorporated HLNE
Clears both ethical standards
An entry written while the outcome is still unknown. It will be scored by what the market does next, and it will never be edited to look cleverer than it was.
read at $85.85
Hamilton Lane Incorporated holds its Distribution at $85.85.
- PHPhase · the trend structure carries the Distribution label
- INInsiders · no filings inside 60 days, left as found
- POPositioning · no disclosures inside 60 days, left as found
- OPOptions · no verdict drawn today, left as found
- SCScreen · passes the values gate
- edge confirmed
- edge broken
- edge forming
Each arm is one independent read. Conviction is not a single call, it is how many edges converge.
The investor read · the season, not the day
| Phase | Distribution · caution |
| Quantitative state | Consolidating, no directional conviction, held for 1 days |
| Price | $85.85 |
| Valuation | 14.50 trailing · 11.70 forward price to earnings |
| Values screen | PASS |
| Beta | 1.17 |
The opportunity · what the numbers say it is worth
Our framework reads AVOID — it trades at roughly a 39% discount to our $119.02 fair value, strong competitive moat.
Price history & projections · where it has been, where the models see it going
The valuation journey · where the price sits against fair value and the Street
Green marks levels above today's price, red below; the shaded band is the gap between the price and our fair value.
Reading the gap · Both our model and the analysts see meaningful upside from here.
| Revenue growth | -2.20% |
| Profit margin | 32.83% |
| Debt to equity | 24.31 |
| Analyst consensus | Buy · 7 covering |
Fair value and rating are our own model estimates; target range reflects third-party analyst estimates. Analysis, not advice.
The values screen, explained · five checks, plain English
This company clears both standards. There are two widely recognised ways to check whether a company is suitable for a Muslim investor. Here is how it did on each:
Used by most halal investing apps ✓ PASSES
The one Titan applies ✓ PASSES
What these two standards are, and how they differ →
- Business activity Its core business isn't built on prohibited lines — no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
- Debt load Interest-bearing debt is just 7.7% of its assets, well under the one-third ceiling — it does not run on borrowed money. Pass
- Interest-bearing cash Cash held in interest-bearing accounts and securities is 7.0% of assets, under the one-third limit. Pass
- Receivables Money owed to the company is 0.0% of assets, under the 49% limit. Pass
- Revenue purity Only 0.0% of revenue comes from non-compliant sources — under the 5% line. Pass
Every security is read against two recognised standards: our stricter asset-based screen (ratios measured against total assets) and the more widely used market-value standard (measured against market capitalisation). Where they agree we say so plainly; where they part ways — almost always on the debt check — we show both readings and mark it, because that disagreement is the finding, not a fault. We report the score; you and your scholar make the call.
The business, in plain words · what the numbers mean
Asset Manager Revenue Shrinks Despite Fat Margins
Hamilton Lane handles private equity commitments for pension funds and endowments that need steady access to illiquid deals. The business posts a 33% profit margin and 32% return on equity, yet revenue has already turned negative and is running 2% lower than last year. That combination alone keeps us away even though the ethical screen clears without issue.
The forward multiple sits at 11.7 times earnings and the shares trade well below our own fair value, but falling sales turn the low multiple into a warning rather than a bargain. Strong moat or not, asset managers live off new commitments and performance fees that dry up when markets slow. Analysts may still cluster around a buy rating, yet the top line trend tells a different story.
Currency moves, fee pressure and slower fundraising cycles all sit on the risk list and could easily extend the revenue slide. A wide moat does not protect against structural shrinkage in assets under management. Analysis, not advice.
| Forward P/E | 11.7x reasonably valued |
| Trailing P/E | 14.5x reasonably valued |
| Revenue growth | -2.2% revenue is shrinking |
| Profit margin | 32.8% highly profitable on every dollar of sales |
| Return on equity | 32.4% an exceptional return on shareholder capital |
| Debt to equity | 0.24 minimal debt — a conservative balance sheet |
| Current ratio | 3.27 comfortably covers its short-term bills |
| Beta | 1.17 moves a little more than the market |
| Market cap | $4.8B |
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Related securities · others in HLNE's space worth a look
Screened names in the same industry · explore each on its own page.
Where & how to trade · wherever in the world you are
HLNE trades on Nasdaq. As a US-listed security it is accessible through almost any international broker offering US markets. New to this, or investing from outside the US? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The trader read · the latest dated commentary
The dated journal · newest first, never edited
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows negative risk-adjusted returns.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows negative risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
The insider ledger · Form 4 filings, as filed
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-24 | BERKMAN DAVID J | Director | 10,000 | $1,010,000 | |
| 2026-02-20 | DELGADO-MOREIRA JUAN | Chief Executive Officer | 9,225 | $989,311 | |
| 2026-02-20 | HIRSCH ERIK R | Chief Executive Officer | 9,225 | $988,260 | |
| 2026-02-20 | KRAMER ANDREA ANIGATI | Chief Operating Officer | 2,325 | $250,011 | |
| 2026-02-06 | DELGADO-MOREIRA JUAN | Chief Executive Officer | 14,375 | · | |
| 2025-12-31 | KRAMER ANDREA ANIGATI | Chief Operating Officer | 92 | $10,522 | |
| 2025-12-31 | CARL DREW THOMAS | Officer | 46 | $5,251 | |
| 2025-11-07 | DELGADO-MOREIRA JUAN | Chief Executive Officer | 8,000 | $1,042,832 | |
| 2025-09-16 | VARON LESLIE F. | Director | 666 | · | |
| 2025-09-16 | SEXTON O GRIFFITH | Director and Beneficial Owner of more than 10% of a Class of Security | 1,331 | · |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
What holding actually paid · price plus dividends
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $88.56 | -12.4% | · | $876 | -12.4% |
| 2 months | $92.28 | -15.9% | · | $841 | -15.9% |
| 3 months | $93.73 | -17.2% | $0.54 | $834 | -16.6% |
| 6 months | $132.05 | -41.2% | $1.08 | $596 | -40.4% |
| 1 year | $149.12 | -48.0% | $2.16 | $535 | -46.5% |
| 2 years | $116.92 | -33.6% | $4.12 | $699 | -30.1% |
| 3 years | $71.79 | +8.1% | $5.90 | $1,163 | +16.3% |
| 5 years | $82.85 | -6.3% | $8.90 | $1,044 | +4.4% |
Historical returns from market close data. Past performance does not guarantee future results.